Gilead Sciences, Inc.
Modulators of toll-like receptors for the treatment of HIV

Abstract:

Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR7, including those of Formula II: ##STR00001## and pharmaceutically acceptable salts thereof, useful in treating HIV infections.